VARIATION OF IMMUNE RESPONSE TO Tp0277, Tp0684, Тр0965 AND Тр1038 TREPONEMA PALLIDUM ANTIGENS IN DIFFERENT SYPHILIS STAGES

Cover Page

Cite item

Full Text

Abstract

The level of IgG antibodies against recombinant proteins Tp0277, Tp0684, Тр0965, Тр1038 of T. pallidum was measured in ELISA assay using blood serum of patients with primary, secondary, early latent and late latent syphilis. We observed certain variations of ELISA diagnostic efficiency with above noted proteins depending on the form of the disease. 100% sensitivity in serodiagnostics of primary syphilis was observed in assays with Tp0277, secondary syphilis – with Tp0965, and early latent syphilis – with Tp1038 recombinant proteins. The highest antibody level against Tp0684 was observed in the group of late latent syphilis patients, but revealed a decreased sensitivity of the assay. The statistical discriminative analysis of the results enabled the development of classification rules for the differentiation of serum samples into four groups according to the stages of syphilis. The efficiency of the proposed classification model revealed 44.4–58.9%, and can be even higher up to 75% using pair­wise comparison of sample groups. To summarize, this approach gives the opportunity for syphilis stage differentiation based on the analysis of antibodies against Treponema pallidum antigens panel.

About the authors

A. V. Runina

State Scientific Centre of Dermatovenereology and Cosmetology, Russian Ministry of Health

Email: fake@neicon.ru

research fellow

Moscow

Russian Federation

A. M. Zatevalov

G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology

Email: fake@neicon.ru

senior research fellow, PhD

Moscow

Russian Federation

G. L. Katunin

State Scientific Centre of Dermatovenereology and Cosmetology, Russian Ministry of Health

Email: fake@neicon.ru

PhD, Head of Syphilidology Department

Moscow

Russian Federation

D. G. Deryabin

State Scientific Centre of Dermatovenereology and Cosmetology, Russian Ministry of Health

Author for correspondence.
Email: dgderyabin@yandex.ru

M.D., Prof., Head of the Department of STD and Dermatoses Laboratory Diagnostics

107076 Moscow, Korolenko Str., 3/6

Russian Federation

A. A. Kubanov

Russian Medical Academy of Post-Graduate Education

Email: fake@neicon.ru

M.D., Prof., corresponding member of RAS, Head of Dermatovenereology and Cosmetology Department

Moscow

Russian Federation

References

  1. Федеральные клинические рекомендации по ведению больных сифилисом. М., РОДВК, 2015, 45 с.
  2. Peeling R.W., Hook E. W. The pathogenesis of syphilis: the Great Mimicker, revisited. J. Pathol. 2006, 208(2), 224–232.
  3. Brinkman M.B., McKevitt M., McLoughlin M., Perez C., Howell J., Weinstock G. M., Norris S. J., Palzkill T. Reactivity of antibodies from syphilis patients to a protein array representing the Treponema pallidum proteome. J. Clin. Microbiol. 2006, 44(3), 888–891.
  4. https://microbeonline.com/laboratory-diagnosis-of-syphilis/
  5. McGill M.A., Edmondson D. G., Carroll J. A., Cook R. G., Orkiszewski R. S., Norris S. J. Characterization and serologic analysis of the Treponema pallidum proteome. Infect. Immun. 2010, 78(6), 2631–2643.
  6. Хайруллин Р.Ф., Ротанов С. В., Фриго Н. В., Белоусова А. В. Биоинформатический анализ специфических антигенов T. pallidum. Вестник дерматологии и венерологии. 2012, 5, 56–64.
  7. Рунина А.В., Рог К. В., Васильев М. М. ТрF1 – новый потенциальный антиген для серодиагностики скрытых форм сифилитической инфекции. Вестник дерматологии и венерологии. 2014, 6, 86–92.
  8. Рунина А.В., Старовойтова А. С., Дерябин Д. Г., Кубанов А. А. Рекомбинантный белок Tp0965 Treponema pallidum как перспективный антиген для совершенствования серологической диагностики сифилиса. Вестник Российской академии медицинских наук. 2016, 71(2), 109–113.
  9. Chamberlain N. R., Brandt M. E., Erwin A. L., Radolf J. D., Norgard M. V. Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infection and immunity. 1989, 57(9), 2872–2877.
  10. Patent WO 2006138324 A2. Treponema pallidum antigens for vaccine development and diagnostic tests.
  11. Long F., Zhang J., Shang G., Shang S., Gong K., Wang Q. Seroreactivity and immunogenicity of Tp0965, a hypothetical membrane protein of Treponema pallidum. Chinese medical journal. 2012, 125(11), 1920–1924.
  12. Zhang R.-L., Zhang J.-P., Wang Q.-Q. Recombinant Treponema pallidum protein Tp0965 activates endothelial cells and increases the permeability of endothelial cell monolayer. PloS one. 2014, 9(12): e115134.
  13. Thumiger A., Polenghi A., Papinutto E., Battistutta R., Montecucco C., Zanotti G. Crystal structure of antigen TpF1 from Treponema pallidum. Proteins. 2006, 62(3), 827–830.
  14. Babolin C., Amedei A., Ozolins D., Zilevica A., D’Elios M.M., de Bernard M. TpF1 from Treponema pallidum activates inflammasome and promotes the development of regulatory T­cells. J. Immunol. 2011, 187(3), 1377–1384.
  15. Brautigam C.A., Deka R. K., Liu W. Z., Norgard M. V. The Tp0684 (MglB­2) lipoprotein of Treponema pallidum: A glucose­binding protein with divergent topology. PLoS one. 2016, 11(8): e0161022.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Runina A.V., Zatevalov A.M., Katunin G.L., Deryabin D.G., Kubanov A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies